Authors:
Cocquyt, V
Van Belie, S
Reinhardt, RR
Decramer, MLA
O'Brien, M
Schellens, JHM
Borms, M
Verbeke, L
Van Aelst, F
De Smet, M
Carides, AD
Eldridge, K
Gertz, BJ
Citation: V. Cocquyt et al., Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis, EUR J CANC, 37(7), 2001, pp. 835-842
Authors:
Van de Wiele, C
Dumont, F
Vanden Broecke, R
Oosterlinck, W
Cocquyt, V
Serreyn, R
Peers, S
Thornback, J
Slegers, G
Dierckx, RA
Citation: C. Van De Wiele et al., Technetium-99m RP527, a GRP analogue for visualisation of GRP receptor-expressing malignancies: a feasibility study, EUR J NUCL, 27(11), 2000, pp. 1694-1699
Authors:
Van Gele, M
Kaghad, M
Leonard, JH
Van Roy, N
Naeyaert, JM
Geerts, ML
Van Belle, S
Cocquyt, V
Bridge, J
Sciot, R
De Wolf-Peeters, C
De Paepe, A
Caput, D
Speleman, F
Citation: M. Van Gele et al., Mutation analysis of P73 and TP53 in Merkel cell carcinoma, BR J CANC, 82(4), 2000, pp. 823-826